Deval Lashkari
InvestorPartner at Telegraph Hill Partners · Board director at Panome Bio · Board director at Community Bio · Board director at Nimble Therapeutics
San Francisco Bay Area
Writes $100K – $5M checks · typically $150K
About
Deval Lashkari is a Senior Partner at Telegraph Hill Partners. He has worked in life science venture capital and private equity, with expertise in diagnostics, business development, and entrepreneurship.
Contact· self-published, not guessed
Board director at Panome Bio
Intro paths
In turn, Deval can intro founders to Panome Bio's investors below.
Panome Bio's investors · 3
Co-founders at Panome Bio


Board director at Community Bio
Intro paths
In turn, Deval can intro founders to Community Bio's investors below.
Community Bio's investors · 1
Board director at Nimble Therapeutics
Intro paths
In turn, Deval can intro founders to Nimble Therapeutics's investors below.
Nimble Therapeutics's investors · 1
Experience
- Telegraph Hill PartnersSenior Partnercurrent2001 — presentSan Francisco Bay Area
- EditCo BioDirector Board of Directorscurrent2024 — present
- n6 TecDirector Board of Directorscurrent2023 — present
- Panome BioDirector Board of Directorscurrent2023 — present
- Mosaic BiosciencesBoardcurrent2022 — present
- ExcellosDirector Board Of Directorscurrent2021 — present
- Cell MicrosystemsDirector Board of Directorscurrent2021 — present
- Nimble TherapeuticsDirector Board Of Directorscurrent2019 — present
- Dynex Technologies, Inc.Director Board Of Directorscurrent2017 — present
- CarterraBoardcurrent2016 — present
- Agena BioscienceDirector Board Of Directors2014 — 2021Acquired by Mesa Labs
- Precision NanoSystems Inc.Director Board Of Directors2015 — 2021Acquired by Danaher
- AsuragenDirector Board Of Directors2017 — 2021Acquired by Bio-Techne
- Akoya Biosciences, Inc.Founding CEO, Director2015 — 2021NASDAQ: AKYA
- SAGE® LabsDirector Board Of Directors2013 — 2015Acquired by Horizon Discovery
- IncyteDirector of Product Development1997 — 1999
- SynteniDirector of Research & Product Development1996 — 1999Acquired by Incyte
- Operon BiotechnologiesStaff Scientist1988 — 1991
Skills & more
+10 more
CommercializationProduct DevelopmentLife SciencesMedical DevicesDue DiligenceCorporate DevelopmentTechnology TransferEntrepreneurshipCross-functional Team LeadershipBiopharmaceuticalsFrom Deval's professional profile.
Deals · 6
Community BioBoard seat
via Telegraph Hill Partners · filed Nov 2021 · $15M raise
Cell MicrosystemsBoard seat
via Telegraph Hill Partners · filed Nov 2021 · $12.7M raise
Precision NanoSystemsBoard seat
via Telegraph Hill Partners · filed Nov 2019 · $6M raise
Nimble TherapeuticsBoard seat
via Telegraph Hill Partners · filed Apr 2019 · $10M raise
Aquaro HistologyBoard seat
via Telegraph Hill Partners · filed Jun 2017 · $9.8M raise
Argonaut Manufacturing ServicesBoard seat
via Telegraph Hill Partners · filed Apr 2016 · $10.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at Telegraph Hill Partners
Network6
Investors connected to Deval in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Deval Lashkari?
- Deval Lashkari is a Senior Partner at Telegraph Hill Partners. He has worked in life science venture capital and private equity, with expertise in diagnostics, business development, and entrepreneurship.
- Where does Deval Lashkari work?
- Deval Lashkari is Partner at Telegraph Hill Partners and Board director at Panome Bio and Board director at Community Bio and Board director at Nimble Therapeutics.
- What check size does Deval Lashkari write?
- Deval Lashkari typically writes checks of $100K – $5M.
- What boards does Deval Lashkari sit on?
- Deval Lashkari holds tracked board seats at Aquaro Histology, Argonaut Manufacturing Services, Cell Microsystems, Community Bio, Nimble Therapeutics, Panome Bio, Precision NanoSystems.
- Where did Deval Lashkari go to school?
- Deval Lashkari studied at Stanford University School of Medicine (PhD, Genetics); University of California, Berkeley (Bachelor of Arts - BA, Genetics).
Same school
Also attended Stanford University School of Medicine83
+ 77 more
Also attended University of California, Berkeley1,453
+ 1,447 more











































